The efficacy and safety of intramuscular aceclofenac and diclofenac for managing postoperative pain in patients undergoing composite resection for oral cancer

Ganashree Puttaswamy , Sarala Narayana , S. M. Azeem Mohiyuddin

Journal of Cancer Metastasis and Treatment ›› 2023, Vol. 9 : 7

PDF
Journal of Cancer Metastasis and Treatment ›› 2023, Vol. 9:7 DOI: 10.20517/2394-4722.2022.84
review-article

The efficacy and safety of intramuscular aceclofenac and diclofenac for managing postoperative pain in patients undergoing composite resection for oral cancer

Author information +
History +
PDF

Abstract

Aim: Non-steroidal anti-inflammatory drugs are the most used analgesics for postoperative pain management. Aceclofenac is a newer phenylacetic acid derivative, and being a predominant cyclooxygenase-2 inhibitor, it has better gastrointestinal tolerability than diclofenac. The aim was to compare the efficacy and safety of aceclofenac and diclofenac in managing postoperative pain using the Face Legs Activity Cry Consolability (FLACC) score and a visual analog scale (VAS) following composite resection for oral cancer.

Methods: Seventy-six patients who underwent composite resection for oral cancer at a tertiary care hospital were randomly assigned to receive either injection of aceclofenac 150 mg or diclofenac 75 mg intramuscularly at 0, 12, 24, 36, 48, and 60 h postoperatively. The FLACC score was recorded at 2, 4, 8, 12, and 24 h, and the VAS score was recorded at 24, 36, 48, 60, and 72 h. Intravenous tramadol 100 mg was given as a rescue analgesic if the FLACC or VAS score was > 3. The patient satisfaction score was recorded at 72 h.

Results: There were 61 female and 15 male patients. Mean surgery durations in the aceclofenac and diclofenac groups were 450.00 ± 116.00 and 416.84 ± 130.63 minutes, respectively. Mean FLACC scores between the two groups were not significantly different. Patients receiving diclofenac had significantly lower mean VAS scores (P = 0.005) at 72 than at 24 h. There was no significant difference in mean VAS scores between groups. The amount of rescue analgesic required in both groups was similar (P = 0.34). At 72 h, 31.57% of patients graded their satisfaction as good in the aceclofenac group and 34.21% in the diclofenac group. Nausea and dyspepsia were common adverse effects in both groups.

Conclusion: Aceclofenac was as effective as diclofenac in reducing postoperative pain following composite resection for oral cancer. In individuals with a history of gastritis or peptic ulcer, aceclofenac can be an alternative to diclofenac.

Keywords

Oral cancer / aceclofenac / diclofenac

Cite this article

Download citation ▾
Ganashree Puttaswamy, Sarala Narayana, S. M. Azeem Mohiyuddin. The efficacy and safety of intramuscular aceclofenac and diclofenac for managing postoperative pain in patients undergoing composite resection for oral cancer. Journal of Cancer Metastasis and Treatment, 2023, 9: 7 DOI:10.20517/2394-4722.2022.84

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Sidransky D. Cancer of head and neck. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology, 7th ed. Philadelphia: Lippincott Williams and Wilkins; 2005. pp. 653-8.

[2]

Gil Z,Marouani N,Fliss DM.Treatment of pain after head and neck surgeries: control of acute pain after head and neck oncological surgeries.Otolaryngol Head Neck Surg2006;135:182-8

[3]

Smirnov G,Tuomilehto H,Seppänen M.Etoricoxib for pain management during thyroid surgery-a prospective, placebo-controlled study.Otolaryngol Head Neck Surg2008;138:92-7

[4]

León-Reyes MR,Ortiz MI.Pharmacokinetics and pharmacodynamics of diclofenac in the presence and absence of glibenclamide in the rat.J Pharm Pharm Sci2008;11:68-76

[5]

Grosser T,Fitzgerald GA. Anti-inflammatory, antipyretic and analgesic agents; pharmacotherapy of gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s The pharmacological basis of therapeutics, 12th ed. New York: Mc Graw Hill; 2011. pp. 959-1005.

[6]

Chunduri NS,Goteki VR,Madasu K.Efficacy of aceclofenac and diclofenac sodium for relief of postoperative pain after third molar surgery: a randomised open label comparative study.J Pharmacol Pharmacother2013;4:144-5 PMCID:PMC3669576

[7]

Patil AK,Amin PD.Comparative study of different formulations of aceclofenac topical drug delivery system and its in vtiro and in vivo characterization.Int J Pharm Sci Res2014;5:3401-08

[8]

Sweetman SC. Martindale the complete drug reference, 38th ed. UK: Pharmaceutical Press; 2014. pp. 3-142.

[9]

Gavhana YN.Improvement in histochemical properties of aceclofenac by using chitosan and water soluble chitosan.Ind J Pharm Pharm Sci2013;5:414-19Available from: https://web.archive.org/web/20180413062808id_/http://ijppsjournal.com/Vol5Suppl1/6483.pdf [Last accessed on 21 March 2023]

[10]

Maheshwari RK.Formulation and evaluation of aceclofenac injection made by mixed hydrotropic solubilization technique.Iran J Pharm Res2010;9:233-42 PMCID:PMC3863437

[11]

Solanki SS.Formulation and evaluation of aceclofenac mouth-dissolving tablet.J Adv Pharm Technol Res2011;2:128-31 PMCID:PMC3217689

[12]

Voepel-Lewis T,Dammeyer JA.Reliability and validity of the face, legs, activity, cry, consolability behavioral tool in assessing acute pain in critically ill patients.Am J Crit Care2010;19:55-61

[13]

Williamson A.Pain: a review of three commonly used pain rating scales.J Clin Nurs2005;14:798-804

[14]

Sankaranarayanan R,Thomas G.Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial.Lancet2005;365:1927-33

[15]

Sharma RG,Verma H.Profile of oral squamous cell cancer in a tertiary level medical college hospital: a 10 yr study.Indian J Surg Oncol2012;3:250-4 PMCID:PMC3444586

[16]

Candau-Alvarez A,Alamillos-Granados FJ.Verrucous carcinoma of the oral mucosa: an epidemiological and follow-up study of patients treated with surgery in 5 last years.Med Oral Patol Oral Cir Bucal2014;19:e506-11 PMCID:PMC4192576

[17]

Lewandowska A,Mucha M.Postoperative pain combating and evaluation of patient’s satisfaction from analgesic treatment.Ann Agric Environ Med2013;1:48-51

[18]

Mahran E.Comparison of pregabalin versus ketamine in postoperative pain management in breast cancer surgery.Saudi J Anaesth2015;9:253-7 PMCID:PMC4478815

[19]

Peng Z,Zhang C,Feng Z.A retrospective study of chronic post-surgical pain following thoracic surgery: prevalence, risk factors, incidence of neuropathic component, and impact on qualify of life.PLoS One2014;9:e90014 PMCID:PMC3938555

[20]

Clarke H,Ko DT,Wijeysundera DN.Rates and risk factors for prolonged opioid use after major surgery: population based cohort study.BMJ2014;348:g1251 PMCID:PMC3921439

[21]

Yadav G,Das SK.Evaluating the role of flupirtine for postcraniotomy pain and compare it with diclofenac sodium: a prospective, randomized, double blind, placebo-controlled study.J Neurosurg Anesthesiol2014;26:32-6

[22]

Imantalab V,Sedighinejad A.Comparing the effects of morphine sulfate and diclofenac suppositories on postoperative pain in coronary artery bypass graft patients.Anesth Pain Med2014;4:e19423 PMCID:PMC4205802

[23]

Sharma V,Rana S.Comparison of efficacy of diclofenac versus aceclofenac in post operative pain in lower limb fractures: a double blind, randomized study.Int J Ortho Surg2012;19:1-15Available from: https://www.semanticscholar.org/paper/Comparison-of-Efficacy-of-Diclofenac-versus-in-Post-Sharma-Awasthi/40d945e77f328b096612f237aa5cc7c59802e842 [Last accessed on 21 March 2023]

[24]

Kılıçkaya R,Ünlügenç H,Işık G.A comparative study of the efficacy of IV dexketoprofen, lornoxicam, and diclophenac sodium on postoperative analgesia and tramadol consumption in patients receiving patient-controlled tramadol.Turk J Anaesthesiol Reanim2015;43:174-80 PMCID:PMC4917186

[25]

Pal A,Mukhopadhyay P,Dasgupta S.Diclofenac is more effective for post-operative analgesia in patients undergoing lower abdominal gynecological surgeries: a comparative study.Anesth Essays Res2014;8:192-6 PMCID:PMC4173621

[26]

Joshi A,Noronha V.Diclofenac versus tramadol for mucositis related pain in head and neck cancer patients undergoing concurrent chemoradiation-a phase 3 study.Ecancermedicalscience2021;15:1318 PMCID:PMC8723742

AI Summary AI Mindmap
PDF

54

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/